HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients.

AbstractBACKGROUND:
Melasma is a common acquired symmetrical hypermelanosis of sun-exposed areas of the skin. Although the classical Q-switched ruby laser (QSRL) has been used successfully for the removal of tattoos and for the treatment of cutaneous pigmented lesions, its efficacy for melasma remains controversial.
OBJECTIVE:
We used repeat low-dose fractional QSRL treatment for melasma and analyzed the clinical results.
METHODS:
Fifteen Korean women with melasma were enrolled. Each patient received six low-dose fractional QSRL treatments to the face at 2-week intervals. Two investigators independently evaluated Melasma Area and Severity Index (MASI) scores before each session and 4 and 16 weeks after the final session. The intensities of pigmentation and erythema were assessed by measuring skin reflectance using a tristimulus color analyzer.
RESULTS:
Mean MASI score decreased from 15.1 ± 3.3 before treatment to 10.6 ± 3.9 16 weeks after the final treatment. The lightness of pigmentation (L-value) increased from 56.6 ± 3.5 before treatment to 59.9 ± 2.8 16 weeks after the final treatment.
CONCLUSIONS:
Multiple treatment sessions of low-dose fractional QSRL may be an effective strategy for the treatment of dermal or mixed-type melasma.
AuthorsWoo Sun Jang, Chang Kyun Lee, Beom Joon Kim, Myeung Nam Kim
JournalDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (Dermatol Surg) Vol. 37 Issue 8 Pg. 1133-40 (Aug 2011) ISSN: 1524-4725 [Electronic] United States
PMID21585597 (Publication Type: Journal Article)
Copyright© 2011 by the American Society for Dermatologic Surgery, Inc.
Topics
  • Adult
  • Dose Fractionation, Radiation
  • Female
  • Humans
  • Lasers, Solid-State (therapeutic use)
  • Low-Level Light Therapy
  • Melanosis (pathology, radiotherapy)
  • Middle Aged
  • Patient Satisfaction
  • Severity of Illness Index
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: